Treatment of Small Cell Lung Cancer James R. Jett, MD, FCCP, Steven E. Schild, MD, Kenneth A. Kesler, MD, FCCP, Gregory P. Kalemkerian, MD CHEST Volume 143, Issue 5, Pages e400S-e419S (May 2013) DOI: 10.1378/chest.12-2363 Copyright © 2013 The American College of Chest Physicians Terms and Conditions
Figure 1 Staging of SCLC: PET or PET/CT scans compared with conventional imaging. CHEST 2013 143, e400S-e419SDOI: (10.1378/chest.12-2363) Copyright © 2013 The American College of Chest Physicians Terms and Conditions
Figure 2 Change in management of SCLC based on PET scan findings. CHEST 2013 143, e400S-e419SDOI: (10.1378/chest.12-2363) Copyright © 2013 The American College of Chest Physicians Terms and Conditions
Figure 3 Etoposide and cisplatin compared with platinum and a topoisomerase inhibitor. CHEST 2013 143, e400S-e419SDOI: (10.1378/chest.12-2363) Copyright © 2013 The American College of Chest Physicians Terms and Conditions
Figure 4 Randomized trials in relapsed small cell lung cancer. CHEST 2013 143, e400S-e419SDOI: (10.1378/chest.12-2363) Copyright © 2013 The American College of Chest Physicians Terms and Conditions
Figure 5 Randomized trials in elderly patients with small cell lung cancer. CHEST 2013 143, e400S-e419SDOI: (10.1378/chest.12-2363) Copyright © 2013 The American College of Chest Physicians Terms and Conditions